| Trial ID: | L1678 |
| Source ID: | NCT00816504
|
| Associated Drug: |
Galactose
|
| Title: |
Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Focal Segmental Glomerulosclerosis
|
| Interventions: |
DRUG: Galactose
|
| Outcome Measures: |
Primary: Reduction in FSGS permeability factor, 28 days |
|
| Sponsor/Collaborators: |
Sponsor: Northwell Health | Collaborators: Medical College of Wisconsin
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-12
|
| Completion Date: |
2009-12
|
| Results First Posted: |
|
| Last Update Posted: |
2015-09-07
|
| Locations: |
Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00816504
|
